Xenon Pharmaceuticals Inc (XENE)
41.84
-0.20
(-0.49%)
USD |
NASDAQ |
Dec 10, 12:22
Xenon Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.0834 |
December 31, 2019 | 0.1689 |
September 30, 2019 | 0.2066 |
June 30, 2019 | 0.1844 |
March 31, 2019 | 0.164 |
December 31, 2018 | 0.1454 |
September 30, 2018 | 0.1339 |
June 30, 2018 | 0.2315 |
Date | Value |
---|---|
March 31, 2018 | 0.2413 |
December 31, 2017 | 0.1893 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | |
December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2020
0.1689
Maximum
Dec 2019
0.021
Average
--
Median
Jun 2020
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 835.90M |
Total Liabilities (Quarterly) | 38.09M |
Shareholders Equity (Quarterly) | 797.81M |